IL17A and hypertensive disorder: Additionally, research indicates that hypertension-induced alterations in cognitive function may be associated with the disruption of the blood-brain barrier and imbalances in angiotensin II, interleukin-6 (IL-6), and interleukin-17 (IL-17) [32–34].